Clinical and Metabolic Parameters in Non-Small Cell Lung Carcinoma and Colorectal Cancer Patients with and without KRAS Mutations

Lung cancer (LC) and colorectal cancer (CRC) are the first and second deadliest types of cancer worldwide. EGFR-based therapy has been used in the treatment of these cancers with variable success. Presence of mutations in the KRAS driver oncogene, possibly induced by environmental factors such as ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Yilmaz, Ahmet, Mohamed, Nehad, Patterson, Kara A., Tang, Yan, Shilo, Konstantin, Villalona-Calero, Miguel A., Davis, Michael E., Zhou, Xiao-Ping, Frankel, Wendy, Otterson, Gregory A., Zhao, Weiqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4198984/
https://www.ncbi.nlm.nih.gov/pubmed/25158139
http://dx.doi.org/10.3390/ijerph110908645

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4198984/
https://www.ncbi.nlm.nih.gov/pubmed/25158139
http://dx.doi.org/10.3390/ijerph110908645

Ejemplares similares